Immix Biopharma Inc.
IMMX | NASDAQ
$7.20
-$0.77 (-9.66%)
At close: Nov 4, 2026, 4:00 PM ET
$7.27
+$0.07 (+0.97%)
After-hours:
Nov 5, 2026, 4:27 PM ET
Fiscal Year Period Ending | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 | FY 2020 Dec 31, 2020 |
|---|---|---|---|---|---|---|
PE Ratio | -5.88 | -2.89 | -7.78 | -3.88 | -0.54 | -24.47 |
PEG Ratio | -0.34 | 0.20 | -0.15 | 0.04 | 0 | 0.51 |
PS Ratio | n/a | n/a | n/a | n/a | n/a | n/a |
PB Ratio | 1.84 | 4.70 | 7.31 | 2.42 | 0.73 | -6.03 |
P/FCF Ratio | -6.99 | -3.95 | -10.50 | -4.29 | -8.22 | -70.50 |
P/OCF Ratio | -7.20 | -4.26 | -10.55 | -4.29 | -8.23 | -70.50 |
OCF/S Ratio | n/a | n/a | n/a | n/a | n/a | n/a |
Debt / Equity Ratio | 0.01 | 0.08 | n/a | n/a | 0 | -0.87 |
Quick Ratio | 10.01 | 2.33 | 5.32 | 11.70 | 90.01 | 0.10 |
Current Ratio | 10.01 | 2.33 | 5.32 | 11.70 | 90.01 | 0.10 |
Asset Turnover | n/a | n/a | n/a | n/a | n/a | n/a |
Interest Coverage | n/a | n/a | n/a | -16.54K | -7.52 | -4.45 |
Return on Equity | -31.39% | -163.10% | -94.03% | -62.54% | -135.54% | 24.26% |
Return on Assets | -28.08% | -94.18% | -77.42% | -55.20% | -134.04% | -212.73% |
Return on Invested Capital | -31.58% | -158.28% | -99.62% | -60.28% | -7.49% | 71.97% |
Dividend Yield | n/a | n/a | n/a | n/a | n/a | n/a |
Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a |
FCF Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit Margin | n/a | n/a | n/a | n/a | n/a | n/a |
Net Profit Margin | n/a | n/a | n/a | n/a | n/a | n/a |
Pretax Profit Margin | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Profit Margin | n/a | n/a | n/a | n/a | n/a | n/a |
FCF Margin | n/a | n/a | n/a | n/a | n/a | n/a |
EBITDA Margin | n/a | n/a | n/a | n/a | n/a | n/a |
Add to Watchlist
Select watchlists to add or remove IMMX